125 related articles for article (PubMed ID: 8395159)
1. Effects of Lambert-Eaton syndrome serum and IgG on calcium and sodium currents in small-cell lung cancer cells.
Viglione MP; Blandino JK; Kim SJ; Kim YI
Ann N Y Acad Sci; 1993 Jun; 681():418-21. PubMed ID: 8395159
[No Abstract] [Full Text] [Related]
2. Inhibition of calcium currents and exocytosis by Lambert-Eaton syndrome antibodies in human lung cancer cells.
Viglione MP; O'Shaughnessy TJ; Kim YI
J Physiol; 1995 Oct; 488 ( Pt 2)(Pt 2):303-17. PubMed ID: 8568672
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient.
Johnston I; Lang B; Leys K; Newsom-Davis J
Neurology; 1994 Feb; 44(2):334-8. PubMed ID: 8309586
[TBL] [Abstract][Full Text] [Related]
4. Neuronal calcium channels as target for Lambert-Eaton myasthenic syndrome autoantibodies.
Sher E; Carbone E; Clementi F
Ann N Y Acad Sci; 1993 Jun; 681():373-81. PubMed ID: 8395151
[No Abstract] [Full Text] [Related]
5. Inhibitory action of Lambert-Eaton syndrome IgG on calcium currents in a thyroid C-cell line.
Kim YI; Blandino JK; O'Shaughnessy TJ
Ann N Y Acad Sci; 1993 Jun; 681():398-401. PubMed ID: 8395154
[No Abstract] [Full Text] [Related]
6. Autoantibody specificities in Lambert-Eaton myasthenic syndrome.
Lang B; Johnston I; Leys K; Elrington G; Marqueze B; Leveque C; Martin-Moutot N; Seagar M; Hoshino T; Takahashi M
Ann N Y Acad Sci; 1993 Jun; 681():382-93. PubMed ID: 8395152
[No Abstract] [Full Text] [Related]
7. Lambert-Eaton syndrome IgG inhibits dihydropyridine-sensitive, slowly inactivating calcium channels in bovine adrenal chromaffin cells.
Blandino JK; Kim YI
Ann N Y Acad Sci; 1993 Jun; 681():394-7. PubMed ID: 8395153
[No Abstract] [Full Text] [Related]
8. Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma.
Meriney SD; Hulsizer SC; Lennon VA; Grinnell AD
Ann Neurol; 1996 Nov; 40(5):739-49. PubMed ID: 8957015
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of voltage-gated calcium channels in small cell carcinomas of patients with and without Lambert-Eaton myasthenic syndrome by autoantibodies omega-conotoxin and adenosine.
De Aizpurua HJ; Lambert EH; Griesmann GE; Olivera BM; Lennon VA
Cancer Res; 1988 Sep; 48(17):4719-24. PubMed ID: 2457429
[TBL] [Abstract][Full Text] [Related]
10. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
11. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
[TBL] [Abstract][Full Text] [Related]
12. Effect of intravenous immunoglobulin in Lambert-Eaton myasthenic syndrome with small-cell lung cancer: correlation with the titer of anti-voltage-gated calcium channel antibody.
Takano H; Tanaka M; Koike R; Nagai H; Arakawa M; Tsuji S
Muscle Nerve; 1994 Sep; 17(9):1073-5. PubMed ID: 8065398
[No Abstract] [Full Text] [Related]
13. Specificity of autoantibodies react with omega-conotoxin MVIIC-sensitive calcium channel in Lambert-Eaton myasthenic syndrome.
Suenaga A; Shirabe S; Nakamura T; Motomura M; Tsujihata M; Matsuo H; Kataoka Y; Niwa M; Itoh M; Nagataki S
Muscle Nerve; 1996 Sep; 19(9):1166-8. PubMed ID: 8761275
[No Abstract] [Full Text] [Related]
14. [Lambert-Eaton myasthenic syndrome].
Sakai K
Ryoikibetsu Shokogun Shirizu; 2000; (31):56-8. PubMed ID: 11269163
[No Abstract] [Full Text] [Related]
15. Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.
Lang B; Pinto A; Giovannini F; Newsom-Davis J; Vincent A
Ann N Y Acad Sci; 2003 Sep; 998():187-95. PubMed ID: 14592874
[TBL] [Abstract][Full Text] [Related]
16. [Autoimmune myasthenia and Lambert-Eaton myasthenic syndrome. Physiopathologic concepts].
Eymard B
Ann Med Interne (Paris); 1989; 140(6):462-6. PubMed ID: 2696402
[TBL] [Abstract][Full Text] [Related]
17. Calcium channel autoantibody and non-small-cell lung cancer in patients with Lambert-Eaton syndrome.
Sher E; Comola M; Nemni R; Canal N; Clementi F
Lancet; 1990 Feb; 335(8686):413. PubMed ID: 1968140
[No Abstract] [Full Text] [Related]
18. Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
Bain PG; Motomura M; Newsom-Davis J; Misbah SA; Chapel HM; Lee ML; Vincent A; Lang B
Neurology; 1996 Sep; 47(3):678-83. PubMed ID: 8797464
[TBL] [Abstract][Full Text] [Related]
19. The Lambert-Eaton syndrome.
Smith RG; Appel SH
Hosp Pract (Off Ed); 1992 Dec; 27(12):101-6, 111-3, 116. PubMed ID: 1333470
[TBL] [Abstract][Full Text] [Related]
20. Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
Leys K; Lang B; Johnston I; Newsom-Davis J
Ann Neurol; 1991 Mar; 29(3):307-14. PubMed ID: 1645944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
